RUTHERFORD, N.J.--(BUSINESS WIRE)--

Cancer Genetics, Inc. (CGIX) (CGI) will present at the UBS Global Healthcare Conference on May 22, 2013 at 12:30 p.m. ET at the Sheraton New York. Panna Sharma, CEO and President, will provide a corporate overview.

The CGI presentation will be webcast live and can be accessed by visiting the investor relations section of the Companys website at http://ir.cancergenetics.com/events.

About Cancer Genetics, Inc.

Cancer Genetics, Inc. (CGI) is an emerging leader in the field of personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual patient. CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our reference laboratory is both CLIA certified and accredited by the College of American Pathologists. In addition, we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey. The company has been built on a foundation of world-class scientific knowledge and IP in solid and hematologic cancers, as well as strong research collaborations with major cancer centers such as Cleveland Clinic and the National Cancer Institute.

CGIs dedicated staff takes pride in our specialized laboratory services, superior turnaround time, enhanced reporting, and ongoing research and development for new oncology tests. CGIs full-service cancer genetic practice and path to innovation with research makes for optimal patient care management. For further information, please seewww.cancergenetics.com.

The rest is here:
Cancer Genetics to Present at UBS Global Healthcare Conference

Comments are closed.